Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,738 | 45 | 96.2% |
| Education | $69.00 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $543.14 | 5 | $0 (2024) |
| ABBVIE INC. | $413.92 | 9 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $262.12 | 4 | $0 (2024) |
| Medtronic, Inc. | $144.95 | 1 | $0 (2023) |
| Covidien LP | $69.00 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.47 | 4 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $48.05 | 4 | $0 (2020) |
| Janssen Biotech, Inc. | $33.38 | 2 | $0 (2021) |
| PFIZER INC. | $31.21 | 2 | $0 (2019) |
| Lilly USA, LLC | $25.14 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $644.77 | 10 | Boston Scientific Corporation ($318.99) |
| 2023 | $412.04 | 4 | Medtronic, Inc. ($144.95) |
| 2022 | $97.32 | 2 | ABBVIE INC. ($97.32) |
| 2021 | $141.13 | 3 | BOSTON SCIENTIFIC CORPORATION ($113.58) |
| 2020 | $111.26 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($37.22) |
| 2019 | $106.48 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($39.73) |
| 2018 | $221.91 | 5 | BOSTON SCIENTIFIC CORPORATION ($110.57) |
| 2017 | $71.80 | 5 | Valeant Pharmaceuticals North America LLC ($20.60) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Boston Scientific Corporation | Resolution 360 Clip (Device) | Food and Beverage | In-kind items and services | $155.91 | General |
| Category: Resolution 360 Clip_ENDO | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Boston Scientific Corporation | Agile Esophageal (Device) | Food and Beverage | In-kind items and services | $88.73 | General |
| Category: Agile_ENDO | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/25/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: INFLIXIMAB | ||||||
| 04/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $74.35 | General |
| Category: EXALT_ENDO | ||||||
| 03/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/24/2023 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $144.95 | General |
| Category: Gastrointestinal AI | ||||||
| 11/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $47.83 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: Neuroscience | ||||||
| 06/02/2021 | BOSTON SCIENTIFIC CORPORATION | EPIC (Device) | Food and Beverage | In-kind items and services | $113.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/26/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Immunology | ||||||
| 11/30/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $10.97 | General |
| Category: GERD | ||||||
| 11/30/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $4.94 | General |
| Category: GERD | ||||||
| 09/23/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2020 | RedHill Biopharma Inc. | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 02/25/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $11.59 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 272 | 292 | $114,851 | $31,764 |
| 2022 | 10 | 328 | 348 | $130,600 | $33,645 |
| 2021 | 10 | 434 | 481 | $238,195 | $45,628 |
| 2020 | 10 | 374 | 409 | $204,761 | $39,284 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 58 | 58 | $35,670 | $11,601 | 32.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 48 | $16,800 | $6,192 | 36.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 57 | $19,095 | $3,923 | 20.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $7,200 | $2,639 | 36.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $22,402 | $2,135 | 9.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 33 | $4,158 | $2,011 | 48.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $5,412 | $1,807 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 22 | $4,114 | $1,458 | 35.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 60 | 62 | $38,130 | $11,084 | 29.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 50 | $17,500 | $7,369 | 42.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 69 | 75 | $25,125 | $5,677 | 22.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 58 | 59 | $28,733 | $3,049 | 10.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 19 | $5,643 | $1,726 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 22 | $4,114 | $1,538 | 37.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $4,950 | $1,228 | 24.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 20 | $2,520 | $1,056 | 41.9% |
| 43450 | Dilation of esophagus | Facility | 2022 | 15 | 15 | $2,880 | $463.54 | 16.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 15 | $1,005 | $453.34 | 45.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 82 | 85 | $27,872 | $13,502 | 48.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 70 | 74 | $77,499 | $12,620 | 16.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 62 | 64 | $45,229 | $4,603 | 10.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 56 | 61 | $42,558 | $4,451 | 10.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 63 | $7,161 | $3,447 | 48.1% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 28 | 29 | $16,763 | $2,567 | 15.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 28 | $4,836 | $2,255 | 46.6% |
About Dr. Lucas Watts, D.O
Dr. Lucas Watts, D.O is a Internal Medicine healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2013. The National Provider Identifier (NPI) number assigned to this provider is 1558604306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lucas Watts, D.O has received a total of $1,807 in payments from pharmaceutical and medical device companies, with $644.77 received in 2024. These payments were reported across 46 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,738).
As a Medicare-enrolled provider, Watts has provided services to 1,408 Medicare beneficiaries, totaling 1,530 services with total Medicare billing of $150,322. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wyoming, MI
- Active Since 03/30/2013
- Last Updated 05/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558604306
Products in Payments
- OCALIVA (Drug) $262.12
- RINVOQ (Biological) $207.49
- SKYRIZI (Biological) $179.43
- Resolution 360 Clip (Device) $155.91
- GI GENIUS (Device) $144.95
- EPIC (Device) $113.58
- CAPTIVATOR (Device) $110.57
- Agile Esophageal (Device) $88.73
- EXALT Model D (Device) $74.35
- PillCam (Device) $69.00
- XIFAXAN (Drug) $68.65
- Entyvio (Biological) $55.47
- STELARA (Biological) $33.38
- OMVOH (Drug) $25.14
- DUPIXENT (Biological) $23.60
- RENFLEXIS (Drug) $17.43
- XELJANZ (Drug) $16.90
- ESOPHYX (Device) $15.91
- Mulpleta (Drug) $14.63
- INFLECTRA (Biological) $14.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyoming
Mounir Ghali, M.d, M.D
Internal Medicine — Payments: $363,968
Dr. Michael Sumners, D.o, D.O
Internal Medicine — Payments: $9,438
Dr. Gunjan Gholkar, M.d, M.D
Internal Medicine — Payments: $7,082
David Tabor, Do, DO
Internal Medicine — Payments: $6,045
Dr. Soheil Assar, Do, DO
Internal Medicine — Payments: $2,492
Gabriel Pedraza, Md, MD
Internal Medicine — Payments: $1,803